Boston Scientific to acquire Valencia Technologies to bolster urology portfolio
Boston Scientific Corp. (NYSE:BSX) has entered into a definitive agreement to acquire Valencia Technologies Corp., a private medical technology firm, in a strategic move to dominate the high-growth market for overactive bladder treatments.











